NO950925L - Preparat og fremgangsmåte for behandling av hårtap - Google Patents

Preparat og fremgangsmåte for behandling av hårtap

Info

Publication number
NO950925L
NO950925L NO950925A NO950925A NO950925L NO 950925 L NO950925 L NO 950925L NO 950925 A NO950925 A NO 950925A NO 950925 A NO950925 A NO 950925A NO 950925 L NO950925 L NO 950925L
Authority
NO
Norway
Prior art keywords
hair loss
preparation
treating hair
tretinoin
hydrocortisone
Prior art date
Application number
NO950925A
Other languages
English (en)
Other versions
NO950925D0 (no
NO311921B1 (no
Inventor
Sandra Brown
Original Assignee
Sandra Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandra Brown filed Critical Sandra Brown
Publication of NO950925D0 publication Critical patent/NO950925D0/no
Publication of NO950925L publication Critical patent/NO950925L/no
Publication of NO311921B1 publication Critical patent/NO311921B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19950925A 1992-09-11 1995-03-10 Anvendelse av preparat for behandling av hårtap NO311921B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94385392A 1992-09-11 1992-09-11
PCT/US1993/008575 WO1994006434A1 (en) 1992-09-11 1993-09-13 Method and composition for the treatment of hair loss

Publications (3)

Publication Number Publication Date
NO950925D0 NO950925D0 (no) 1995-03-10
NO950925L true NO950925L (no) 1995-05-09
NO311921B1 NO311921B1 (no) 2002-02-18

Family

ID=25480381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19950925A NO311921B1 (no) 1992-09-11 1995-03-10 Anvendelse av preparat for behandling av hårtap

Country Status (14)

Country Link
EP (1) EP0659080B1 (no)
JP (1) JPH08501552A (no)
AT (1) ATE202935T1 (no)
AU (1) AU684470B2 (no)
CA (1) CA2144416C (no)
DE (1) DE69330429T2 (no)
DK (1) DK0659080T3 (no)
ES (1) ES2159294T3 (no)
FI (1) FI951126A (no)
GR (1) GR3036827T3 (no)
NO (1) NO311921B1 (no)
NZ (1) NZ256271A (no)
PT (1) PT659080E (no)
WO (1) WO1994006434A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344448B1 (en) * 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp
JP2002322050A (ja) * 2001-04-25 2002-11-08 Kenji Uehara 発毛剤
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
FR2929117B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
FR2929118B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
FR2949052B1 (fr) 2009-08-13 2015-03-27 Oreal Procede de traitement cosmetique du cuir chevelu.
WO2011076721A1 (en) 2009-12-22 2011-06-30 Deutsches Krebsforschungszentrum Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases
US9861645B2 (en) * 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
EP0625045A4 (en) * 1992-02-07 1995-01-18 Albert M Kligman METHODS OF TREATING INFLAMMATORY DERMATOSIS.

Also Published As

Publication number Publication date
EP0659080A4 (en) 1997-11-12
NZ256271A (en) 1997-03-24
PT659080E (pt) 2001-10-31
FI951126A0 (fi) 1995-03-10
FI951126A (fi) 1995-03-10
EP0659080A1 (en) 1995-06-28
AU4857393A (en) 1994-04-12
DE69330429D1 (de) 2001-08-16
CA2144416A1 (en) 1994-03-31
EP0659080B1 (en) 2001-07-11
AU684470B2 (en) 1997-12-18
DE69330429T2 (de) 2002-05-16
ATE202935T1 (de) 2001-07-15
DK0659080T3 (da) 2001-09-17
GR3036827T3 (en) 2002-01-31
NO950925D0 (no) 1995-03-10
JPH08501552A (ja) 1996-02-20
WO1994006434A1 (en) 1994-03-31
NO311921B1 (no) 2002-02-18
ES2159294T3 (es) 2001-10-01
CA2144416C (en) 2003-12-30

Similar Documents

Publication Publication Date Title
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
NO875045D0 (no) Fremgangsmaate for fremstilling av topiske preparater for behandling av akne.
AU3432989A (en) Product and method for the treatment of acne etc.
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
AU3068684A (en) Preparation and method for the treatment of acne
DE68907423D1 (de) Behandlung der akne.
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
NO950925L (no) Preparat og fremgangsmåte for behandling av hårtap
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
FR2720070B1 (fr) Procédé de préparation d'alkylpolysiloxanes pontés et alkylpolysiloxanes pontés.
AU5682790A (en) Method of treating tinea
NO892505D0 (no) Behandling av vandige dispersjoner.
AU2685892A (en) Method of treating blood
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
AU4259193A (en) Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
AU562435B2 (en) Substituted cyclopropenone for the treatment of alopecia areata and other dermatological diseases
NO981020L (no) Transdermalt terapautisk system for silatranforbindelser
NO902968L (no) Fremgangsmaate for behandling av boreslam.
AU8689291A (en) Method for the treatment of fleas
NO873478D0 (no) Fremgangsmaate for helbredelse av benskade samt preparat dertil.
AU2234083A (en) Treatment of sub-clinical and acute mastitis
ATE91231T1 (de) Behandlung der akne.
AU7377491A (en) Dr M and Zenni method of treatment by electro-stimulations of the central nervous system
NO905643L (no) Fremgangsmaate for behandling av manganslam.